-
CHANGES IN BREAST CANCER SCREENING PREVALENCE FOLLOWING UPDATED USPSTF MAMMOGRAPHY GUIDELINES: DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS
Mar 18, 2026, 21:38 PM -
HOSPITAL DRUG MARK-UPS IN THE UNITED STATES: A SYSTEMATIC REVIEW OF ACADEMIC AND POLICY LITERATURE
Mar 18, 2026, 21:38 PM -
VALIDATED ECONOMIC TOOL TO MEASURE THE DIRECT COSTS FOR PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION (IPAH) AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) IN COLOMBIA
Mar 18, 2026, 21:38 PM -
EMBEDDED QUALITATIVE INTERVIEWS - GUIDANCE AND PRACTICE BY MAJOR HTA BODIES
Mar 18, 2026, 21:38 PM -
PHYSICAL AND MENTAL HEALTH STATUS AND PRODUCTIVITY LOSS ASSOCIATED WITH MIGRAINE: A REAL-WORLD EVIDENCE ANALYSIS USING A NATIONALLY REPRESENTATIVE US COHORT
Mar 18, 2026, 21:38 PM -
THE DIVERSITY OF HEALTH ACCESS IN THE US: A GEOSPATIAL ANALYSIS OF INTEGRATED DELIVERY NETWORKS AND AFFILIATED MEDICARE PROVIDERS
Mar 18, 2026, 21:38 PM -
COMPARISON OF DRUG AFFORDABILITY DECISIONS ACROSS STATE-LEVEL PRESCRIPTION DRUG AFFORDABILITY BOARDS AND THE CENTERS FOR MEDICARE AND MEDICAID SERVICES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SLEEP AND PSYCHOLOGICAL WELL-BEING IN U.S. AND SOUTH KOREAN ADOLESCENTS
Mar 18, 2026, 21:38 PM -
SYSTEMATIC LITERATURE REVIEW OF LIMITATIONS IN THE HYPOTHYROIDISM TREATMENT PARADIGM: CHALLENGES TO STABLE CONTROL AND QUALITY OF LIFE
Mar 18, 2026, 21:38 PM -
IMPACT OF MEDICATION ADHERENCE ON CLINICAL AND ECONOMIC OUTCOMES IN TYPE 2 DIABETES: A SCOPING REVIEW OF REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
MANAGEMENT OF CHILDHOOD ACUTE OTITIS MEDIA WITH OR WITHOUT ORAL ANTIBIOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
THE IMPACT OF THE FIRST FAMILY CORONAVIRUS RESPONSE ACT ON HEALTHCARE SERVICE UTILIZATION AMONG MEDICAID BENEFICIARIES WITH SICKLE CELL DISEASE IN WISCONSIN
Mar 18, 2026, 21:38 PM -
LONG-TERM OUTCOMES OF FIBROMYALGIA PATIENTS WITH AND WITHOUT INSOMNIA: A REAL-WORLD COHORT STUDY
Mar 18, 2026, 21:38 PM -
FRAMEWORK FOR RWD TRANSFORMATIONS FROM NATIVE DATA MODELS TO CDISC DATA STANDARDS
Mar 18, 2026, 21:38 PM -
UPTAKE OF BIOSIMILARS TO INSULIN GLARGINE IN 2021-2025 IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
CHEMOTHERAPY-BASED VERSUS TARGET-BASED TREATMENT FOR PATIENTS WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER WHO PROGRESSED ON FIRST-LINE TKIS THERAPY: A TARGET TRIAL EMULATION IN CHINA
Mar 18, 2026, 21:38 PM -
EFFICACY AND SAFETY OF NEWLY APPROVED ANTI-TUBERCULOSIS DRUGS IN MDR-TUBERCULOSIS, TB-HIV, AND TB-CANCER POPULATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS OF SOCIODEMOGRAPHIC AND CLINICAL FACTORS WITH GLP-1 RECEPTOR AGONIST UTILIZATION AMONG U.S. ADULTS WITH DIABETES, A CROSS-SECTIONAL ANALYSIS OF 2024 NHIS DATA
Mar 18, 2026, 21:38 PM -
PATIENT-CENTERED INSIGHTS INTO THE BURDEN AND IMPACT OF HERPES ZOSTER IN ADULTS AGED 50-64 YEARS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
TARGET POPULATION SIZE AND LAUNCH PRICE DYNAMICS OF CELL AND GENE THERAPIES (CGTS)
Mar 18, 2026, 21:38 PM
